REGENEREX PHARMA, INC. Shareholders' Equity
REGENEREX PHARMA, INC. had Shareholders' Equity of -$5.00 million as of 2025-12-31, per its 10-KT filed 2026-08-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-31
- 2025-12-31: Stockholders' Equity Attributable to Parent -$5.00M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$4.70M.
- 2025-06-30: Stockholders' Equity Attributable to Parent -$4.55M.
- 2025-03-31: Stockholders' Equity Attributable to Parent -$4.16M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2025-12-31 | -$5.00M 10-KT · filed 2026-08-31 | |
| 2025-09-30 | -$4.70M 10-Q · filed 2025-11-17 | |
| 2025-06-30 | -$4.55M 10-Q · filed 2025-11-17 | |
| 2025-03-31 | -$4.16M 10-KT · filed 2026-08-31 | |
| 2024-12-31 | -$5.05M 10-Q · filed 2025-02-07 | |
| 2024-09-30 | -$4.76M 10-Q · filed 2025-11-17 | |
| 2024-06-30 | -$4.31M 10-Q · filed 2025-11-17 | |
| 2024-03-31 | -$4.06M 10-KT · filed 2026-08-31 | |
| 2023-12-31 | -$3.88M 10-Q · filed 2025-02-07 | |
| 2023-09-30 | -$3.63M 10-Q · filed 2025-02-07 | |
| 2023-06-30 | -$1.08M 10-Q · filed 2024-11-04 | |
| 2023-03-31 | -$1.12M 10-K · filed 2025-06-30 | |
| 2022-12-31 | -$1.08M 10-Q · filed 2024-02-05 | |
| 2022-09-30 | -$1.03M 10-Q · filed 2024-02-05 | |
| 2022-06-30 | -$1.01M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | -$985.62K 10-K · filed 2024-06-24 | |
| 2021-12-31 | -$937.17K 10-Q · filed 2023-01-24 | |
| 2021-09-30 | -$902.73K 10-Q · filed 2023-01-24 | |
| 2021-06-30 | -$868.98K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | -$835.03K 10-K · filed 2023-06-09 | |
| 2021-03-21 | -$835.03K 10-K · filed 2022-06-28 | |
| 2020-12-31 | -$550.55K 10-Q/A · filed 2022-02-03 | |
| 2020-09-30 | -$516.86K 10-Q/A · filed 2022-02-03 | |
| 2020-06-30 | -$491.09K 10-Q · filed 2021-11-01 | |
| 2020-03-31 | -$481.27K 10-K · filed 2022-06-28 | |
| 2019-12-31 | -$440.98K 10-Q · filed 2021-02-11 | |
| 2019-09-30 | -$420.42K 10-Q · filed 2021-02-11 | -$420.43K 10-Q · filed 2019-10-30 |
| 2019-06-30 | -$401.95K 10-Q · filed 2020-11-10 | |
| 2019-03-31 | -$369.69K 10-K · filed 2021-06-23 | |
| 2018-12-31 | -$353.23K 10-Q · filed 2020-02-10 | |
| 2018-09-30 | -$344.49K 10-Q · filed 2019-10-30 | |
| 2018-06-30 | -$339.68K 10-Q/A · filed 2019-07-29 | |
| 2018-03-31 | -$321.11K 10-K/A · filed 2020-08-11 | |
| 2017-12-31 | -$317.36K 10-Q · filed 2018-02-08 | |
| 2017-09-30 | -$306.92K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | -$298.79K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | -$321.11K 10-K · filed 2019-06-24 | -$281.69K 10-Q · filed 2017-08-07 |
| 2016-03-31 | -$279.11K 10-K · filed 2018-06-21 | |
| 2014-11-30 | -$795.39K 10-K · filed 2015-03-03 | -$693.48K 10-Q · filed 2014-07-23 |
| 2014-08-31 | -$742.71K 10-Q · filed 2014-10-20 | |
| 2014-05-31 | -$693.48K 10-Q · filed 2014-07-23 | |
| 2014-02-28 | -$1.86M 10-Q · filed 2014-04-11 | |
| 2013-11-30 | -$1.70M 10-K · filed 2015-03-03 | |
| 2012-11-30 | -$749.66K 10-K · filed 2015-03-03 | |
| 2012-08-31 | -$285.06K 10-Q · filed 2012-10-15 | |
| 2012-05-31 | -$280.64K 10-Q · filed 2012-07-16 | |
| 2011-11-30 | -$122.34K 10-K · filed 2013-02-28 | |
| 2011-08-31 | $339.08K 10-Q · filed 2011-10-13 | |
| 2010-11-30 | -$22.84K 10-Q · filed 2011-10-13 | |
| 2010-08-31 | -$13.82K 10-Q · filed 2011-10-13 | |
| 2010-05-20 | $15.50K 10-K · filed 2015-03-03 | |
| 2009-11-30 | -$8.47K 10-Q · filed 2011-10-13 | |
| 2008-11-29 | -$2.53K 10-Q · filed 2011-10-13 |